Isoflurane-Based Inhaled Sedation in Mechanically Ventilated Adults With Acute Hypoxemic Respiratory Failure
Angela Jerath, Marat Slessarev, Claudio Martin, Frédérick D’Aragon, François Martin Carrier, Janek Manoj Senaratne, Hilary Meggison, Jonathan Hooper, Yiorgos Alexandros Cavayas, Ewan C. Goligher, Étienne J. Couture, Ian M. Randall, Roupen Hatzakorzian, Michael J. Jacka, Jeanine P. Wiener-Kronish, Zhongcong Xie, Ruxandra L Pinto, Iman Hussain, Brian H. Cuthbertson, SAVE-ICU Investigators and the Canadian Critical Care Trials Group, Martin Chapman, Damon C. Scales, Julie Nardi, Beth Linseman, Phil Lau, Eily Shaw, Lilia Kaustov, John Basmaji, Ahmed F. Hegazy, Eileen Campbell, Michelle Stephens, Vimoshana Vijayakumar, Brenda Morgan, Lynne Kelly, Irina Zaborovskaya, Tracey Bentall, Tim Winterburn, Courtney Hooper, Michelle Alexander, Maxime Tissot-Therrien, François Lamontagne, Dominique Bérard, Michaël Chassé, Martin Girard, Han-Ting Wang, Vito Nobile Fidanza, Brenda Lécuyer, Andréa Gagnon-Hamelin, Mélissa Gagnon-Hamelin, Francesca Lamothe and 10 more
Peer-reviewed journalReal-world use
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Conclusions and Relevance In mechanically ventilated adults with AHRF, an inhaled sedation strategy using isoflurane with intravenous adjuncts as clinically needed did not reduce hospital mortality compared with an intravenous sedation strategy.
We report VG-3927, an oral, CNS-penetrant small-molecule TREM2 agonist that engages the transmembrane domains of TREM2 and its adaptor DAP12 to promote higher-order receptor complex formation and downstream signaling.
Borislav Dejanovic, Matthew D. Figley, Elizabeth F. Weisman and 19 more — Science Translational Medicine
Peer-reviewed journalClaims a big stepReal-world use
Here we present a machine-learning system that predicts clinical trial success across phases I-IV, independently modeling studies with efficacy versus safety/toxicity primary endpoints.
Furthermore, NZEP TA-Ce treatment reverses gut microbiota dysbiosis and optimizes the composition of microbial metabolites, thereby alleviating anxiety and depressive symptoms associated with IBD.
Fan Zhang, Lei Chen, Shengfu Wang and 9 more — Nature Communications
Peer-reviewed journalBold claims, read criticallyReal-world use
ConclusionsAmong critically ill patients with acute kidney injury who had indications for renal-replacement therapy, intermittent hemodialysis as the initial treatment approach was not shown to be noninferior to continuous renal-replacement therapy with respect to major adverse kidney events by day 90 and was associated with higher mortality.
Stèphane Gaudry, Marouane Boubaya, Guillaume Louis and 42 more — New England Journal of Medicine